Research ArticleTUMOR IMMUNOLOGY

Impaired enolase 1 glycolytic activity restrains effector functions of tumor-infiltrating CD8+ T cells

See allHide authors and affiliations

Science Immunology  25 Jan 2019:
Vol. 4, Issue 31, eaap9520
DOI: 10.1126/sciimmunol.aap9520

Article Information

vol. 4 no. 31

PubMed: 
Published By: 
History: 
  • Received September 13, 2017
  • Revision received August 10, 2018
  • Accepted December 3, 2018
  • .

Author Information

  1. Lelisa F. Gemta1,
  2. Peter J. Siska2,3,
  3. Marin E. Nelson4,
  4. Xia Gao5,
  5. Xiaojing Liu5,
  6. Jason W. Locasale5,
  7. Hideo Yagita6,
  8. Craig L. Slingluff Jr.7,
  9. Kyle L. Hoehn8,
  10. Jeffrey C. Rathmell3 and
  11. Timothy N. J. Bullock1,*
  1. 1Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA.
  2. 2Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany.
  3. 3Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  4. 4Department of Pharmacology, University of Virginia, VA 22908, USA.
  5. 5Department of Pharmacology and Cancer Biology, Duke University, NC 27710, USA.
  6. 6Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
  7. 7Department of Surgery, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
  8. 8School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, Australia.
  1. *Corresponding author. Email: TB5V{at}virginia.edu

Altmetric

Article usage

Article usage: January 2019 to December 2019

AbstractFullPdf
Jan 201922064571036
Feb 20199661451422
Mar 201960014286
Apr 20192806435
May 20192205538
Jun 20192565937
Jul 20191613617
Aug 20192203529
Sep 20191513218
Oct 20191593319
Nov 20191673426
Dec 20191922